InsiderClue
Stocks · Health care · Services-Health Services

GeneDx Holdings Corp.

WGS Clue Score60
United States Fiscal year ends December CIK 0001818331 Results filed 3 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

46
Insider
Date
Role
Action
Shares
Price
Amount
Katherine Stueland
4 Mar 2026
Chief Executive Officer
Sell
9,133
$79.25
$723.78K
Katherine Stueland
4 Mar 2026
Chief Executive Officer
Sell
10,465
$78.61
$822.62K
Katherine Stueland
4 Mar 2026
Chief Executive Officer
Sell
5,861
$77.63
$454.97K
Kevin Feeley
4 Mar 2026
Chief Financial Officer
Sell
2,220
$79.25
$175.93K
Kevin Feeley
4 Mar 2026
Chief Financial Officer
Sell
2,543
$78.61
$199.90K
Kevin Feeley
4 Mar 2026
Chief Financial Officer
Sell
1,424
$77.63
$110.54K
Kevin Feeley
2 Mar 2026
Chief Financial Officer
Sell
287
$77.52
$22.25K
Bryan Dechairo
2 Feb 2026
Chief Operating Officer
Sell
1,166
$100.31
$116.97K
Bryan Dechairo
2 Feb 2026
Chief Operating Officer
Sell
1,662
$99.40
$165.20K
Bryan Dechairo
2 Feb 2026
Chief Operating Officer
Sell
492
$98.61
$48.52K
Bryan Dechairo
2 Feb 2026
Chief Operating Officer
Sell
93
$96.77
$9.00K
Joshua Ruch
24 Nov 2025
Director
Sell indirect
728
$162.04
$117.96K
Joshua Ruch
24 Nov 2025
Director
Sell indirect
11,234
$161.16
$1.81M
Joshua Ruch
24 Nov 2025
Director
Sell indirect
8,944
$160.45
$1.44M
Joshua Ruch
24 Nov 2025
Director
Sell indirect
6,279
$159.28
$1.00M
Joshua Ruch
24 Nov 2025
Director
Sell indirect
2,016
$158.40
$319.34K
Joshua Ruch
24 Nov 2025
Director
Sell indirect
147
$162.04
$23.82K
Joshua Ruch
24 Nov 2025
Director
Sell indirect
2,268
$161.16
$365.50K
Joshua Ruch
24 Nov 2025
Director
Sell indirect
1,805
$160.45
$289.61K
Joshua Ruch
24 Nov 2025
Director
Sell indirect
1,268
$159.28
$201.96K
Joshua Ruch
24 Nov 2025
Director
Sell indirect
407
$158.40
$64.47K
Joshua Ruch
24 Nov 2025
Director
Sell indirect
72
$162.04
$11.67K
Joshua Ruch
24 Nov 2025
Director
Sell indirect
1,117
$161.16
$180.01K
Joshua Ruch
24 Nov 2025
Director
Sell indirect
889
$160.45
$142.64K
Joshua Ruch
24 Nov 2025
Director
Sell indirect
625
$159.28
$99.55K
Joshua Ruch
24 Nov 2025
Director
Sell indirect
201
$158.40
$31.84K
Kevin Feeley
2 Sep 2025
Chief Financial Officer
Sell
378
$125.81
$47.56K
Jason Ryan
27 Aug 2025
Director
Sell
1,150
$129.65
$149.09K
Jason Ryan
27 Aug 2025
Director
Sell indirect
1,500
$130.01
$195.02K
Jason Ryan
27 Aug 2025
Director
Sell indirect
9,890
$129.59
$1.28M
Jason Ryan
27 Aug 2025
Director
Sell indirect
3,452
$128.04
$442.00K
Jason Ryan
27 Aug 2025
Director
Sell indirect
5,443
$127.44
$693.64K
Jason Ryan
27 Aug 2025
Director
Sell indirect
8,969
$126.15
$1.13M
Jason Ryan
27 Aug 2025
Director
Sell indirect
8,818
$125.07
$1.10M
Casdin Capital, LLC
22 Aug 2025
Director
Sell indirect
500,000
$120.90
$60.45M
Kevin Feeley
2 Jun 2025
Chief Financial Officer
Sell
370
$71.26
$26.37K
Kevin Feeley
17 Mar 2025
Chief Financial Officer
Sell
3,749
$96.71
$362.57K
Katherine Stueland
17 Mar 2025
Chief Executive Officer
Sell
10,559
$96.71
$1.02M
Kevin Feeley
13 Mar 2025
Chief Financial Officer
Sell
402
$90.05
$36.20K
Katherine Stueland
13 Mar 2025
Chief Executive Officer
Sell
1,078
$89.44
$96.42K
Katherine Stueland
10 Mar 2025
Chief Executive Officer
Sell
2,731
$94.73
$258.70K
Kevin Feeley
10 Mar 2025
Chief Financial Officer
Sell
922
$94.72
$87.33K
Kevin Feeley
3 Mar 2025
Chief Financial Officer
Sell
261
$103.94
$27.13K
Kevin Feeley
2 Jan 2025
Chief Financial Officer
Sell
337
$77.04
$25.96K
Kevin Feeley
2 Jan 2025
Chief Financial Officer
Sell
774
$76.00
$58.82K
Kevin Feeley
2 Jan 2025
Chief Financial Officer
Sell
319
$75.08
$23.95K
Showing 250 of 457 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 389
Amendments (4/A) skipped 14
Filings about a different issuer 0
Unreadable filings 0
Joint filings 24
Sales on a Rule 10b5-1 plan 64
Sales straight out of an exercise 139
Sales at will 183
Transactions with no price 0
Shares from compensation/vesting 150,817,325
Sales filed before the plan box existed 38
History held since 26 Jul 2021